Anemia
News
Drug receives orphan designation for treatment of PNH
The US Food and Drug Administration (FDA) has granted orphan drug designation to ACH-4471 for the treatment of paroxysmal nocturnal hemoglobinuria...
News
Ferric citrate approved to treat iron-deficiency anemia
The US Food and Drug Administration (FDA) has approved ferric citrate (Auryxia) to treat iron-deficiency anemia in adults with chronic kidney...
News
FDA approves wider use of hematology analyzer
The US Food and Drug Administration (FDA) has expanded the approved use of the XW-100 Automated Hematology Analyzer. The analyzer can now be used...
Feature
Sickle cell patients suffer discrimination, poor care – and shorter lives
Sickle cell disease is “a microcosm of how issues of race, ethnicity and identity come into conflict with issues of health care.”
News
Drug receives fast track designation for lower-risk MDS
The US Food and Drug Administration (FDA) has granted fast track designation to the telomerase inhibitor imetelstat. The designation is for...
News
ATLG fights GVHD but reduces PFS, OS
Results of a phase 3 trial suggest rabbit anti-T lymphocyte globulin (ATLG) can reduce graft-versus-host disease (GVHD) but also decrease survival...
News
System automates classification of RBCs
Scientists say they have developed an automated system that can identify shapes of red blood cells (RBCs). The team found their system could...
News
Eltrombopag can control ITP long-term, study suggests
Eltrombopag can provide long-term disease control for chronic/persistent immune thrombocytopenia (ITP), according to research published in Blood...
From the Journals
Guidelines cut acute chest syndrome hospital returns in pediatric sickle cell
Treatment with recommended antibiotics reduced hospital readmissions for acute chest syndrome in children with sickle cell disease.
News
Team devises new method to analyze cells
Biophysicists have developed a new method to determine a cell’s mechanical properties, and they believe this method could provide insights...
News
FDA rejects pegfilgrastim biosimilar
The US Food and Drug Administration (FDA) has issued a complete response letter saying the agency cannot approve MYL-1401H, a proposed biosimilar...